Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block

• Status: Withdrawn
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, randomized, double blind study of adding dexmedetomidine to ropivacaine for Brachial plexus block and assessing the analgesia with VAS pain scales(0-10), Satisfaction scale by VAS scale(0-10) and time to first analgesic consumption. This study mainly aims to investigate whether addition of dexmedetomidine helps in increasing the duration of analgesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Florida
• Treatments: Dexmedetomidine; Ropivacaine

Criteria

Inclusion Criteria:

• Age-18years and above

• Both male and female patients

• BMI->18

• Elective Subacute upper extremity fractures

Exclusion Criteria:

• Chronic pain patients (Pain persisting for more than 3-6months or past the normal healing time of any injury, influences every aspect of a person's quality of life.)

• Patients with drug abuse history in the past 6 months

• ESRD

• Hepatic failure